These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 17166981

  • 1. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR, Warren DK, Kollef MH, Fridkin SK, Fraser VJ.
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [Abstract] [Full Text] [Related]

  • 2. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D, Hilbert G, Vargas F, Valentino R, Bui N, Pereyre S, Bebear C, Bebear CM, Gbikpi-Benissan G.
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [Abstract] [Full Text] [Related]

  • 3. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
    Arnold HM, Hollands JM, Skrupky LP, Smith JR, Juang PH, Hampton NB, McCormick S, Reichley RM, Hoban A, Hoffmann J, Micek ST, Kollef MH.
    Ann Pharmacother; 2013 Feb; 47(2):170-80. PubMed ID: 23341160
    [Abstract] [Full Text] [Related]

  • 4. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients.
    Warren DK, Hill HA, Merz LR, Kollef MH, Hayden MK, Fraser VJ, Fridkin SK.
    Crit Care Med; 2004 Dec; 32(12):2450-6. PubMed ID: 15599150
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
    Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi A, Frank U, Mertens K, Schumacher M, Wolkewitz M.
    Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
    [Abstract] [Full Text] [Related]

  • 6. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D, De Bels D, Forêt F, Cran S, Gilbert E, Schoonheydt K, Blot S, ANTHICUS Study Investigators.
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [Abstract] [Full Text] [Related]

  • 7. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM.
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
    Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD.
    Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
    [Abstract] [Full Text] [Related]

  • 9. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
    Quillici MCB, Resende DS, Gonçalves IR, Royer S, Sabino SS, Almeida VF, Ribas RM, Gontijo Filho PP.
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258755
    [Abstract] [Full Text] [Related]

  • 10. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes.
    Sligl WI, Dragan T, Smith SW.
    Int J Infect Dis; 2015 Aug; 37():129-34. PubMed ID: 26159847
    [Abstract] [Full Text] [Related]

  • 11. Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
    Alves MD, Ribeiro VB, Tessari JP, Mattiello F, De Bacco G, Luz DI, Vieira FJ, Behle TF, Pasqualotto AC, Zavascki AP.
    J Antimicrob Chemother; 2014 Jun; 69(6):1681-7. PubMed ID: 24474430
    [Abstract] [Full Text] [Related]

  • 12. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
    Wei HJ, Liu LL, Xiaoli LY, Wang YP, Huang D, Pian HY, Zhu YC.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
    [Abstract] [Full Text] [Related]

  • 13. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS, Loeb M, Brooks AA.
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [Abstract] [Full Text] [Related]

  • 14. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.
    Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V.
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1040-8. PubMed ID: 9351601
    [Abstract] [Full Text] [Related]

  • 15. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
    Sostarich AM, Zolldann D, Haefner H, Luetticken R, Schulze-Roebecke R, Lemmen SW.
    Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
    [Abstract] [Full Text] [Related]

  • 16. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA.
    BMC Infect Dis; 2014 Nov 25; 14():615. PubMed ID: 25420613
    [Abstract] [Full Text] [Related]

  • 17. Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen.
    Hedrick TL, Schulman AS, McElearney ST, Smith RL, Swenson BR, Evans HL, Truwit JD, Scheld WM, Sawyer RG.
    Surg Infect (Larchmt); 2008 Apr 25; 9(2):139-52. PubMed ID: 18426346
    [Abstract] [Full Text] [Related]

  • 18. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices.
    Kollef MH, Ward S, Sherman G, Prentice D, Schaiff R, Huey W, Fraser VJ.
    Crit Care Med; 2000 Oct 25; 28(10):3456-64. PubMed ID: 11057801
    [Abstract] [Full Text] [Related]

  • 19. Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital.
    Tian H, Chen L, Wu X, Li F, Ma Y, Cai Y, Song S.
    Dig Dis Sci; 2020 Jul 25; 65(7):2079-2088. PubMed ID: 31691173
    [Abstract] [Full Text] [Related]

  • 20. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.
    Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, Peleman R, Claeys G, Verschraegen G, Colardyn F, Vandewoude K.
    Infect Control Hosp Epidemiol; 2005 Jun 25; 26(6):575-9. PubMed ID: 16018434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.